HomeBiotech

Biotech

Remegen’s Innovative New Drug Telitacicept(RC18) Obtains Positive Phase III Results, Submitted for Second Indication for Treatment of Rheumatoid Arthritis

Remegen’s Innovative New Drug Telitacicept(RC18) Obtains Positive Phase III Results, Submitted for Second Indication for Treatment of Rheumatoid Arthritis

September 27, 2023

IDEAYA Receives Fast Track Designation for Potential First-in-Class PARG Inhibitor, IDE161, for Treatment of Pretreated, Platinum-Resistant Advanced or Metastatic Ovarian Cancer Patients having tumors with BRCA1/2 Mutations

IDEAYA Receives Fast Track Designation for Potential First-in-Class PARG Inhibitor, IDE161, for Treatment of Pretreated, Platinum-Resistant Advanced or Metastatic Ovarian Cancer Patients having tumors with BRCA1/2 Mutations

September 26, 2023

Global Next Generation Sequencing (NGS) Informatics Research Analysis Report 2023-2030: DNASTAR, Fabric Genomics, Partek, and DNAnexus Drive NGS Informatics Innovations

Global Next Generation Sequencing (NGS) Informatics Research Analysis Report 2023-2030: DNASTAR, Fabric Genomics, Partek, and DNAnexus Drive NGS Informatics Innovations

September 26, 2023

Infectious Disease Research Through Unmet Needs Analysis, Pipeline Assessment, Disease Intelligence, Pricing Strategies, and Market Access Analysis by Disease Landscape Insights

Infectious Disease Research Through Unmet Needs Analysis, Pipeline Assessment, Disease Intelligence, Pricing Strategies, and Market Access Analysis by Disease Landscape Insights

September 26, 2023

WuXi Vaccines Launches Its First Vaccines CDMO Site in China

WuXi Vaccines Launches Its First Vaccines CDMO Site in China

September 26, 2023

Global Neoantigen Cancer Vaccine Research Report 2023-2031: Regulatory Pathways and Neoantigen Vaccines Navigating the Future of Cancer Immunotherapy

Global Neoantigen Cancer Vaccine Research Report 2023-2031: Regulatory Pathways and Neoantigen Vaccines Navigating the Future of Cancer Immunotherapy

September 25, 2023

Global ATP Assays Market Research Report 2023-2027: Opportunities in Technological Enhancements in ATP Assay Probes & Growth Prospects in Emerging Economies

Global ATP Assays Market Research Report 2023-2027: Opportunities in Technological Enhancements in ATP Assay Probes & Growth Prospects in Emerging Economies

September 25, 2023

Epidemiology of Pancreatic Cancer- Market Access, Statistics, Comprehensive Insights for Stakeholders and Regulatory Guidelines | Disease Landscape Insights

Epidemiology of Pancreatic Cancer- Market Access, Statistics, Comprehensive Insights for Stakeholders and Regulatory Guidelines | Disease Landscape Insights

September 25, 2023

Omixon Launches NanoTYPE MONO™ and MONOall™ RUO, a Singleplex Human Leukocyte Antigen Amplification kit compatible with Oxford Nanopore’s MinION™ Platform

Omixon Launches NanoTYPE MONO™ and MONOall™ RUO, a Singleplex Human Leukocyte Antigen Amplification kit compatible with Oxford Nanopore’s MinION™ Platform

September 25, 2023

MediLink Therapeutics: Focuses on ADC research and development to promote new prospects for cancer treatment

MediLink Therapeutics: Focuses on ADC research and development to promote new prospects for cancer treatment

September 24, 2023

« 1 … 30 31 32 33 34 … 75 »